Cinfa Banks On ‘Multi-Layered’ Scientific Advice As It Files For EU Pegfilgrastim Biosimilar Review
Executive Summary
Cinfa Biotech is hoping that the advice it received from the EU regulators during the development of its pegfilgrastim biosimilar will help it succeed where others have failed.